A Scaleable Synthesis of BAY 43-9006: A Potent Raf Kinase Inhibitor for the Treatment of Cancer
- 20 September 2002
- journal article
- review article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 6 (6), 777-781
- https://doi.org/10.1021/op020205n
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- New Substituted 1-(2,3-Dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl Derivatives with α2-Adrenoceptor Antagonist ActivityJournal of Medicinal Chemistry, 2000
- The discovery of potent cRaf1 kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2000
- Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinaseNature Medicine, 1996
- Improved Large-Scale Preparation of 4-Iodopicolinic AcidSynthetic Communications, 1996
- Synthesis and antiulcer activity of N-substituted N'-[3-[3-(piperidinomethyl)phenoxy]propyl]ureas: histamine H2-receptor antagonists with potent mucosal protective activityJournal of Medicinal Chemistry, 1992
- Serine- and threonine-specific protein kinase activities of purified gag–mil and gag–raf proteinsNature, 1984
- HETEROCYCLIC BASIC COMPOUNDS. XVI. 4-CHLOROPICOLINIC ACID AND SOME OF ITS DERIVATIVESThe Journal of Organic Chemistry, 1955
- Über die Einwirkung von Thionylchlorid auf die Pyridin‐monocarbonsäurenBerichte der deutschen chemischen Gesellschaft (A and B Series), 1928